(Q43796650)

26 November 2017

Status of a group B Neisseria meningitidis vaccine (English)

1 reference

26 November 2017

Neisseria meningitidis

1 reference

1

C E Frasch

1 reference

26 November 2017

1 December 1985

1 reference

European journal of clinical microbiology

26 November 2017

1 reference

26 November 2017

4

1 reference

26 November 2017

6

1 reference

26 November 2017

533-536

1 reference

Immunologic response of man to group B meningococcal polysaccharide vaccines.

26 November 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02013388

Serotypes and polyacrylamide gel electrophoresis types among disease-associated isolates of group B Neisseria meningitidis in Spain, 1976-1979.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02013388

Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02013388

Experimental meningococcal infection in neonatal mice: differences in virulence between strains isolated from human cases and carriers

21 January 2018

1 reference

12 December 2020

Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model

1 reference

12 December 2020

Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135.

1 reference

12 December 2020

Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model

1 reference

12 December 2020

Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most nonpathogenic Neisseria species

1 reference

12 December 2020

1 reference

12 December 2020

Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.

1 reference

12 December 2020

Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model

1 reference

12 December 2020

Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens

1 reference

12 December 2020

Response of Neisseria gonorrhoeae to iron limitation: alterations in expression of membrane proteins without apparent siderophore production

1 reference

12 December 2020

Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis

1 reference

12 December 2020

Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978

1 reference

12 December 2020

Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations

1 reference

12 December 2020

Meningococcal meningitis in Royal Air Force recruits

1 reference

12 December 2020

Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes

1 reference

12 December 2020

Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in Man

1 reference

12 December 2020

Meningococcal Disease: Still with Us

1 reference

12 December 2020

Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotyping

1 reference

12 December 2020

Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis

1 reference

12 December 2020

Safety of vaccines containing meningococcal group B polysaccharide

1 reference

12 December 2020

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02013388

1 reference

26 November 2017

1 reference

PubMed ID

3937731